Telix Pharmaceuticals Files New Drug Submission with Health Canada for Prostate Cancer Imaging Product
Telix has filed a New Drug Submission (NDS) with Health Canada for TLX591-CDx (Kit for the preparation...
Read moreLatest News
Category: News
Telix Pharmaceuticals and Mauna Kea Technologies Launch Urologic Oncology Alliance
Telix Pharmaceuticals announces collaboration with Mauna Kea Technologies to develop advanced image-guided surgical technologies in the field of urologic...
Read more
Telix and Kanazawa University Commence Japanese Clinical Study for Prostate Cancer Imaging
Telix announces its subsidiary, Telix Pharmaceuticals Japan KK, has entered a clinical study collaboration with Kanazawa University (Japan) for the conduct of a Phase I trial of its prostate cancer...
Read more
Telix Completes IP Agreement with the University of Southampton (UK) Granting Exclusive Access to TRALA Clinical Trial Data
Telix Pharmaceuticals Limited announces today that its wholly-owned subsidiary TheraPharm GmbH has completed an Intellectual Property (IP) agreement with the University of Southampton,...
Read more
Telix Granted TGA Priority Review for Prostate Cancer Imaging
Telix has been granted Priority Review status for TLX591-CDx (68Ga-PSMA-11), a radiopharmaceutical for the imaging of prostate cancer using Positron Emission Tomography...
Read more
Telix and DuChemBio Announce Korean Partnership for Advanced Prostate Cancer Imaging
Telix Pharmaceuticals announces it has entered into a licensing and partnership agreement with...
Read more
Telix Receives Approval for First-In-Human Study of Next Generation Prostate Cancer Therapy Product
Telix has been granted HREC approval and received CTN clearance by the TGA to commence Phase I study of the Company’s next generation prostate cancer therapy product TLX592, in patients...
Read more
Investor Briefing – TheraPharm GmbH Acquisition
Telix Pharmaceuticals Provides Investor Briefing: TheraPharm GmbH...
Read more
Investor Conference Call: Telix’s acquisition of TheraPharm GmbH
Telix advises it will hold an investor conference call to provide further detail in relation to Telix’s acquisition of TheraPharm...
Read more
Telix Pharmaceuticals Limited Acquires TheraPharm GmbH
Telix announces it has entered into an agreement with Scintec Diagnostics GmbH to acquire TheraPharm GmbH, a Swiss-German biotechnology company developing innovative diagnostic and therapeutic solutions in the field of...
Read more